SEGMENTS, GEOGRAPHIC INFORMATION AND MAJOR CUSTOMER DATA (Schedule of financial information with respect to single operating segment) (Details) - USD ($) $ in Thousands |
6 Months Ended | |||
|---|---|---|---|---|
Jun. 30, 2026 |
Jun. 30, 2025 |
|||
| Revenues from External Customers and Long-Lived Assets [Line Items] | ||||
| Total revenues | $ 4,778 | $ 3,541 | ||
| Financial income, net | (3,191) | (2,315) | ||
| Taxes on income | 12 | 14 | ||
| Net loss | (14,675) | (14,523) | ||
| Single Operating Segment [Member] | ||||
| Revenues from External Customers and Long-Lived Assets [Line Items] | ||||
| Total revenues | 4,778 | 3,541 | ||
| Preclinical R&D expenses | 7,858 | 6,659 | ||
| Clinical R&D expenses | 8,824 | 6,982 | ||
| SG&A | 5,438 | 4,851 | ||
| Financial income, net | (3,189) | (2,314) | ||
| Taxes on income | 12 | 14 | ||
| Other segment expenses | [1] | 510 | 1,872 | |
| Net loss | $ (14,675) | $ (14,523) | ||
| ||||
| X | ||||||||||
- Definition Amount of expense for research and development. Includes, but is not limited to, cost for computer software product to be sold, leased, or otherwise marketed and writeoff of research and development assets acquired in transaction other than business combination or joint venture formation or both. Excludes write-down of intangible asset acquired in business combination or from joint venture formation or both, used in research and development activity. No definition available.
|
| X | ||||||||||
- Definition Financial Income (Expense), Net. No definition available.
|
| X | ||||||||||
- Definition Other segment expenses. No definition available.
|
| X | ||||||||||
- Definition Amount of expense for research and development. Includes, but is not limited to, cost for computer software product to be sold, leased, or otherwise marketed and writeoff of research and development assets acquired in transaction other than business combination or joint venture formation or both. Excludes write-down of intangible asset acquired in business combination or from joint venture formation or both, used in research and development activity. No definition available.
|
| X | ||||||||||
- Definition Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The portion of profit or loss for the period, net of income taxes, which is attributable to the parent. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss). Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Details
|